Newsletter Signup | Community
Updated clinical trial results reveal Tivozanib superior to Nexavar and headed to the FDA for US approval.
Recent suggests that combining an immune PD-1 checkpoint inhibitor with a TKI to treat advanced RCC is promising.
Siblings of Kidney Cancer Patients at Increased Risk for the Disease.
Cancer Connect - Treatment of Stages I - III Kidney Cancer
Combination of precision cancer medicines may represent new treatment strategy for advanced renal cell cancer.
Cancer Connect - Treatment of Recurrent Kidney Cancer
Precision cancer medicines and immunotherapy is the mainstay of stage IV Kidney Cancer treatment.
